Safety of Ixekizumab in Patients With Psoriatic Arthritis: Results From a Pooled Analysis of Three Clinical Trials

OBJECTIVE: To evaluate ixekizumab safety in adults with psoriatic arthritis (PsA). METHODS: Safety data from 2 integrated data sets are presented: 1) 24‐week, double‐blind, placebo‐controlled period of SPIRIT‐P1 and SPIRIT‐P2; and 2) all ixekizumab‐treated patients of SPIRIT‐P1 and SPIRIT‐P2 plus SP...

Descripción completa

Detalles Bibliográficos
Autores principales: Mease, Philip, Roussou, Euthalia, Burmester, Gerd‐Rüdiger, Goupille, Philippe, Gottlieb, Alice, Moriarty, Susan R., Benichou, Olivier, Adams, David H., Xu, Wen, Nash, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Psoriatic Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593968/
https://www.ncbi.nlm.nih.gov/pubmed/30156760
http://dx.doi.org/10.1002/acr.23738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593968/
https://www.ncbi.nlm.nih.gov/pubmed/30156760
http://dx.doi.org/10.1002/acr.23738

Ejemplares similares